INC Research Holdings, Inc. (NASDAQ:INCR) was downgraded by research analysts at Robert W. Baird to an “outperform” rating in a report released on Friday. They currently have a $46.00 price objective on the stock, down from their prior price objective of $67.00. Robert W. Baird’s price objective would indicate a potential upside of 17.65% from the company’s current price.

Other equities research analysts have also issued research reports about the stock. Zacks Investment Research raised shares of INC Research Holdings from a “hold” rating to a “buy” rating and set a $58.00 target price on the stock in a report on Wednesday, September 27th. TheStreet lowered shares of INC Research Holdings from a “b” rating to a “c” rating in a report on Friday, July 28th. Goldman Sachs Group, Inc. (The) reaffirmed a “buy” rating and issued a $65.00 target price on shares of INC Research Holdings in a report on Monday, August 7th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $62.50 target price on shares of INC Research Holdings in a report on Sunday, July 30th. Finally, BidaskClub lowered shares of INC Research Holdings from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. INC Research Holdings presently has a consensus rating of “Buy” and a consensus target price of $57.89.

Shares of INC Research Holdings (NASDAQ INCR) traded down $2.05 during trading on Friday, reaching $39.10. 1,899,500 shares of the company’s stock traded hands, compared to its average volume of 873,748. The company has a market cap of $4,079.89, a price-to-earnings ratio of 17.94, a PEG ratio of 1.17 and a beta of 1.36. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.27 and a quick ratio of 1.27. INC Research Holdings has a 12-month low of $38.25 and a 12-month high of $61.10.

INC Research Holdings (NASDAQ:INCR) last posted its earnings results on Thursday, November 9th. The company reported $0.54 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.63 by ($0.09). INC Research Holdings had a positive return on equity of 14.42% and a negative net margin of 4.29%. The firm had revenue of $592.21 million during the quarter, compared to the consensus estimate of $604.95 million. During the same period in the previous year, the company posted $0.64 EPS. The firm’s revenue for the quarter was up 128.2% compared to the same quarter last year. sell-side analysts forecast that INC Research Holdings will post 2.3 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This news story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of international copyright laws. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/11/13/inc-research-holdings-inc-incr-rating-lowered-to-outperform-at-robert-w-baird.html.

In related news, CEO Alistair Macdonald sold 8,828 shares of the company’s stock in a transaction dated Thursday, August 17th. The shares were sold at an average price of $55.65, for a total transaction of $491,278.20. Following the transaction, the chief executive officer now owns 110,629 shares in the company, valued at approximately $6,156,503.85. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Gregory S. Rush sold 41,420 shares of the company’s stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $58.26, for a total transaction of $2,413,129.20. Following the transaction, the chief financial officer now owns 42,793 shares in the company, valued at approximately $2,493,120.18. The disclosure for this sale can be found here. In the last quarter, insiders have sold 198,321 shares of company stock worth $11,550,792. 0.24% of the stock is owned by corporate insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Strs Ohio lifted its position in INC Research Holdings by 0.8% during the 2nd quarter. Strs Ohio now owns 25,200 shares of the company’s stock worth $1,474,000 after buying an additional 200 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in INC Research Holdings by 14.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,765 shares of the company’s stock valued at $103,000 after purchasing an additional 228 shares during the period. Victory Capital Management Inc. lifted its position in INC Research Holdings by 17.6% during the 2nd quarter. Victory Capital Management Inc. now owns 2,377 shares of the company’s stock valued at $139,000 after purchasing an additional 356 shares during the period. Oregon Public Employees Retirement Fund lifted its position in INC Research Holdings by 4.9% during the 3rd quarter. Oregon Public Employees Retirement Fund now owns 20,946 shares of the company’s stock valued at $1,095,000 after purchasing an additional 986 shares during the period. Finally, Principal Financial Group Inc. lifted its position in INC Research Holdings by 2.6% during the 1st quarter. Principal Financial Group Inc. now owns 44,821 shares of the company’s stock valued at $2,055,000 after purchasing an additional 1,154 shares during the period. Institutional investors and hedge funds own 77.75% of the company’s stock.

INC Research Holdings Company Profile

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Analyst Recommendations for INC Research Holdings (NASDAQ:INCR)

Receive News & Stock Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related stocks with our FREE daily email newsletter.